Kinaset Doses First Patient in Phase 2b PANAIRAMA Asthma Trial
Kinaset Therapeutics Doses First Patient in Phase 2b Trial of Frevecitinib for Severe Asthma Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for serious respiratory diseases,…
Immunomic Therapeutics Doses First Patient in Phase 1 ITI-5000 Trial
Immunomic Therapeutics Doses First Patient in Phase 1 Trial of ITI-5000 Therapeutic Cancer Vaccine for Triple-Negative Breast Cancer Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company and U.S.-based subsidiary of…
Clinigen Appoints Greg Skalicky as Chief Executive Officer
Clinigen Appoints Greg Skalicky as Group CEO to Lead Next Phase of Global Growth and Patient Access Strategy Clinigen, a global pharmaceutical services company dedicated to improving patient access to…
Bayer and Henry Ford Health Partner to Expand Clinical Trial Access
Bayer and Henry Ford Health Form Strategic Partnership to Expand Patient Access to Clinical Trials and Accelerate Medical Innovation Bayer, a global life sciences company with a broad portfolio spanning…
iVeena Delivery Systems Completes Phase 1 Trial of IVMED-85
iVeena Delivery Systems Completes Phase 1 Trial of IVMED-85, Advancing Novel Eye Drop Therapy for Pediatric Myopia iVeena Delivery Systems, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing innovative…
Aptar Pharma Launches Integrated Injectable Drug Development Framework
Aptar Pharma Introduces Collaborative System-Level Framework to Advance Injectable Drug Delivery Development Aptar Pharma, a global leader in drug delivery, dosing, protection technologies, and pharmaceutical services, has announced the launch…
Veradermics Presents Phase 2/3 Hair Loss Data at AAD Innovation Academy 2026
Veradermics Presents New Phase 2/3 Data Highlighting the Potential of VDPHL01 for Male Pattern Hair Loss Across Age Groups Veradermics, Incorporated, a late-stage biopharmaceutical company founded by dermatologists and dedicated…
LianMedical Announces Successful Merger Completion
LianMedical Completes Merger with LianBio and Launches New Chapter as Medical Device Innovation Company LianMedical, formerly known as LianBio, has announced the successful completion of its previously disclosed corporate merger,…
Takeda Reports Positive Phase 3 Results for Zasocitinib in Psoriasis
Takeda Reports New Phase 3 Data Showing Zasocitinib Delivers Strong Skin Clearance Across Difficult-to-Treat Areas in Plaque Psoriasis Takeda has announced new findings from its two pivotal Phase 3 clinical…
Mirador Therapeutics Expands Immunology Portfolio with KP-301 License
Mirador Therapeutics Expands Precision Immunology Pipeline Through Global Licensing Agreement for KP-301 Mirador Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision medicines for immune-mediated inflammatory and fibrotic diseases,…
Cutera® and Restimulate Health™ Partner to Advance Rehabilitation Technology
Cutera and Restimulate Health Partner to Advance Technology-Driven Rehabilitation with truFlex Integration CUTERA, INC., a global provider of aesthetic and dermatologic technologies, has announced a strategic partnership with Restimulate Health,…
Anova and Nouveau Biosciences Partner to Advance Kromastat Clinical Trials for T-Cell Lymphoma
Anova Enterprises and Nouveau Biosciences Partner to Advance Clinical Development of Kromastat for Hard-to-Treat Cancers Anova Enterprises, Inc., a technology-enabled contract research organization (CRO) dedicated to accelerating the development of…